Results 181 to 190 of about 1,886,614 (303)

Navigating Chinese-led economic integration: a comparative study of commercial dispute resolution and public policy exceptions in Cambodia, Pakistan and Thailand. [PDF]

Front Sociol
Yaseen M, Phattanasin K, Pathak S.
europepmc   +1 more source

Catalytic Hydrothermal Liquefaction of Polyethylene With Pt/C to Tune Product Selectivity

CleanMat, EarlyView.
Pt/C‐catalyzed hydrothermal liquefaction of polyethylene in supercritical water enables time‐dependent control of product selectivity, producing paraffin‐rich oils at shorter reaction times and aromatic‐enriched products at longer times without external hydrogen. ABSTRACT Hydrothermal liquefaction (HTL) represents a promising thermochemical pathway for
Taofeng Lu, Wan‐Ting Chen
wiley   +1 more source

From Criminal Liability to Patient Safety: The Possible Impact of the Italian 2025 Reform Proposal on Senior Healthcare Leadership and Clinical Risk Management. [PDF]

Healthcare (Basel)
La Micela S, Stevanin G, Pancheri A, Faes C, Bonetti A, Atti S, Tocco Tussardi I, Tardivo S.   +7 more
europepmc   +1 more source

Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance

Clinical Pharmacology &Therapeutics, EarlyView.
Regulatory bodies play a central role in providing guidance that enables safe and effective use of artificial intelligence tools in medicine development and evaluation. Regulators can also act as catalysts for regulatory science research. To inform these efforts, a European‐wide survey was conducted to solicit stakeholder perspectives on the priority ...
Luis C. Pinheiro, Amanda C. Langston, Marie Orre, Joerg Zinserling, Konstantina Boumaki, Bastian V. H. Hornung, Siobhan O'Sullivan, Gabriel Westman, Karl Broich, Peter Arlett   +9 more
wiley   +1 more source

AI in the OR: Ethics and the Evolving Role of Surgeons. [PDF]

J Med Internet Res
Congdon J.
europepmc   +1 more source

Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA‐Authorised Medicines

Clinical Pharmacology &Therapeutics, EarlyView.
Evidence on the efficacy and safety of medicines supporting marketing authorization is largely derived from randomized controlled trials, yet these trials often exclude populations likely to use the medications in clinical practice. This study assessed eligibility of special populations, defined as pregnant and breast‐feeding individuals, elderly ...
Maja J. Jørgensen, Débora D. Gräf, Christine E. Hallgreen   +2 more
wiley   +1 more source

Strengthening global biosecurity for synthetic nucleic acid technology: from sequence screening to risk-based governance in the AI era. [PDF]

Front Bioeng Biotechnol
Kato SE, Ndudzo A, Bayiga SO, Brenda N, Serwaa C, Baluku E, Mang'anda H, Peter JJ, Shamirah K, Perez M, Tawiah RN, Anguzu S, Malemia S.   +12 more
europepmc   +1 more source

Ethical Behaviour and Corporate Financing. The Case of ‘Legality Rating’

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The financial crisis has heightened awareness of ethical and legal issues in the business context. Corporate ethical behaviour is increasingly measured through sustainability ratings. Since 2012, in Italy, the introduction of a sustainability rating, namely the legality rating (LR), has served as an innovative ‘label’ for socially responsible ...
Federica Doni, Lucio Masserini, Zeila Occhipinti, Roberto Verona   +3 more
wiley   +1 more source

Algorithmic governance at work: a legal-sociological and policy analysis of AI regulation, institutional power and labor rights. [PDF]

Front Sociol
Olimid AP, Georgescu CM, Olimid DA, Georgescu SD, Gherghe CL.   +4 more
europepmc   +1 more source